Skip to main content
. 2016 Jun 16;12(2):1211–1215. doi: 10.3892/ol.2016.4740

Table II.

Clinical response rates and survival data (entire study population, n=29).

Relapse (n=20), n

Clinical response <6 months 6–12 months %
Complete remission 0 1   5
Partial remission 0 3 15
Stable disease 3 3 30
Progressive disease 5 3 40
Not evaluable 2 0 10